Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer.

Datta J, Smith JJ, Chatila WK, McAuliffe JC, Kandoth C, Vakiani E, Frankel TL, Ganesh K, Wasserman I, Lipsyc-Sharf M, Guillem J, Nash GM, Paty PB, Weiser MR, Saltz LB, Berger MF, Jarnagin WR, Balachandran V, Kingham TP, Kemeny NE, Cercek A, Garcia-Aguilar J, Taylor BS, Viale A, Yaeger R, Solit DB, Schultz N, D'Angelica MI.

Clin Cancer Res. 2019 Nov 12. doi: 10.1158/1078-0432.CCR-19-2390. [Epub ahead of print]

PMID:
31719050
2.

Feasibility and efficacy of gamification in general surgery residency: Preliminary outcomes of residency teams.

McAuliffe JC, McAuliffe RH Jr, Romero-Velez G, Statter M, Melvin WS, Muscarella P 2nd.

Am J Surg. 2019 Nov 6. pii: S0002-9610(19)31155-9. doi: 10.1016/j.amjsurg.2019.10.051. [Epub ahead of print]

PMID:
31718815
3.

Perioperative Mortality Does Not Explain Racial Disparities in Gastrointestinal Cancer.

Bliton J, Muscarella P, Friedmann P, Parides M, Papalezova K, McAuliffe JC, In H.

J Gastrointest Surg. 2019 Aug;23(8):1631-1642. doi: 10.1007/s11605-018-4064-7. Epub 2019 Jan 16.

PMID:
30652243
4.

Prevalence of False-Negative Results of Intraoperative Consultation on Surgical Margins During Resection of Gastric and Gastroesophageal Adenocarcinoma.

McAuliffe JC, Tang LH, Kamrani K, Olino K, Klimstra DS, Brennan MF, Coit DG.

JAMA Surg. 2019 Feb 1;154(2):126-132. doi: 10.1001/jamasurg.2018.3863.

5.

Randomized Controlled Trials in Neuroendocrine Tumors.

McAuliffe JC, Wolin EM.

Surg Oncol Clin N Am. 2017 Oct;26(4):751-765. doi: 10.1016/j.soc.2017.05.012. Epub 2017 Aug 4. Review.

PMID:
28923229
6.

"Adjuvant" Hyperthermic Intraperitoneal Chemotherapy: A Call to Action.

McAuliffe JC, Nash GM.

Ann Surg Oncol. 2017 Jan;24(1):11-12. doi: 10.1245/s10434-016-5496-5. Epub 2016 Aug 10. No abstract available.

PMID:
27510843
7.

Isolation of isoprene degrading bacteria from soils, development of isoA gene probes and identification of the active isoprene-degrading soil community using DNA-stable isotope probing.

El Khawand M, Crombie AT, Johnston A, Vavlline DV, McAuliffe JC, Latone JA, Primak YA, Lee SK, Whited GM, McGenity TJ, Murrell JC.

Environ Microbiol. 2016 Sep;18(8):2743-53. doi: 10.1111/1462-2920.13345. Epub 2016 Jun 30.

PMID:
27102583
8.

Hepatic resection, hepatic arterial infusion pump therapy, and genetic biomarkers in the management of hepatic metastases from colorectal cancer.

McAuliffe JC, Qadan M, D'Angelica MI.

J Gastrointest Oncol. 2015 Dec;6(6):699-708. doi: 10.3978/j.issn.2078-6891.2015.081. Review.

9.

Type 2 diabetes mellitus and pancreatic cancer.

McAuliffe JC, Christein JD.

Surg Clin North Am. 2013 Jun;93(3):619-27. doi: 10.1016/j.suc.2013.02.003. Epub 2013 Apr 3. Review.

PMID:
23632148
10.

Should pancreatectomy with islet cell autotransplantation in patients with chronic alcoholic pancreatitis be abandoned?

Dunderdale J, McAuliffe JC, McNeal SF, Bryant SM, Yancey BD, Flowers G, Christein JD.

J Am Coll Surg. 2013 Apr;216(4):591-6; discussion 596-8. doi: 10.1016/j.jamcollsurg.2012.12.043.

PMID:
23521936
11.

Computed tomography attenuation and patient characteristics as predictors of complications after pancreaticoduodenectomy.

McAuliffe JC, Parks K, Kumar P, McNeal SF, Morgan DE, Christein JD.

HPB (Oxford). 2013 Sep;15(9):709-15. doi: 10.1111/hpb.12037. Epub 2013 Jan 10.

12.

Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST).

Gupta A, Roy S, Lazar AJ, Wang WL, McAuliffe JC, Reynoso D, McMahon J, Taguchi T, Floris G, Debiec-Rychter M, Schoffski P, Trent JA, Debnath J, Rubin BP.

Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14333-8. doi: 10.1073/pnas.1000248107. Epub 2010 Jul 26.

13.

Unlucky number 13? Differential effects of KIT exon 13 mutation in gastrointestinal stromal tumors.

McAuliffe JC, Wang WL, Pavan GM, Pricl S, Yang D, Chen SS, Lazar AJ, Pollock RE, Trent JC.

Mol Oncol. 2008 Aug;2(2):161-3. doi: 10.1016/j.molonc.2008.05.002. Epub 2008 May 10. No abstract available.

14.

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.

McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC.

Ann Surg Oncol. 2009 Apr;16(4):910-9. doi: 10.1245/s10434-008-0177-7. Epub 2008 Oct 25.

15.

Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.

McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6727-34.

16.

Clinical, histopathologic, molecular and therapeutic findings in a large kindred with gastrointestinal stromal tumor.

Kleinbaum EP, Lazar AJ, Tamborini E, Mcauliffe JC, Sylvestre PB, Sunnenberg TD, Strong L, Chen LL, Choi H, Benjamin RS, Zhang W, Trent JC.

Int J Cancer. 2008 Feb 1;122(3):711-8.

17.
18.

Imatinib mesylate in the treatment of gastrointestinal stromal tumour.

Steinert DM, McAuliffe JC, Trent JC.

Expert Opin Pharmacother. 2005 Jan;6(1):105-13. Review.

PMID:
15709888
19.

Update on the biology and therapy of gastrointestinal stromal tumors.

D'Amato G, Steinert DM, McAuliffe JC, Trent JC.

Cancer Control. 2005 Jan-Feb;12(1):44-56. Review.

PMID:
15668652
20.

Synthesis of O-glycolyl-linked neuraminic acids through a spirocyclic intermediate.

McAuliffe JC, Rabuka D, Hindsgaul O.

Org Lett. 2002 Sep 5;4(18):3067-9.

PMID:
12201718
21.

Synthesis of selectively radiolabeled hexasaccharides for the determination of enzymatic regioselectivity.

McAuliffe JC, Ujita M, Fukuda M, Hindsgaul O.

Glycoconj J. 1999 Dec;16(12):767-72.

PMID:
11133016
22.

Expedient synthesis of a series of N-acetyllactosamines.

McAuliffe JC, Fukuda M, Hindsgaul O.

Bioorg Med Chem Lett. 1999 Oct 4;9(19):2855-8.

PMID:
10522705
23.

Supplemental Content

Loading ...
Support Center